Elon Musk's brain-implant company Neuralink on Thursday said it had received U.S. regulatory approval for human trials for the first time.
This is a major milestone for the company after an earlier rejection reportedly over safety concerns.
Elon Musk’s Neuralink Brain Chip Can Now Be Tested On Humans
You might like
Related news coverage
Advertisement
More coverage
Neuralink Receives FDA Approval For In-Human Clinical Trials
Wibbitz Top Stories
Neuralink Receives FDA Approval , For In-Human Clinical Trials.
On May 25, Elon Musk's neurotech startup..
